Graypoint LLC’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$705K Sell
8,761
-445
-5% -$34.3K 0.04% 265
2025
Q1
$739K Buy
9,206
+4,372
+90% +$364K 0.05% 251
2024
Q4
$396K Buy
4,834
+259
+6% +$21.6K 0.02% 359
2024
Q3
$377K Buy
4,575
+68
+2% +$5.08K 0.02% 362
2024
Q2
$316K Buy
4,507
+265
+6% +$18.9K 0.02% 373
2024
Q1
$314K Buy
4,242
+288
+7% +$20.1K 0.02% 365
2023
Q4
$261K Sell
3,954
-981
-20% -$61.4K 0.02% 374
2023
Q3
$310K Buy
+4,935
New +$307K 0.03% 324
2023
Q1
Sell
-2,793
Closed -$202K 364
2022
Q4
$202K Buy
+2,793
New +$200K 0.02% 321
2022
Q2
Sell
-3,265
Closed -$229K 319
2022
Q1
$229K Buy
+3,265
New +$221K 0.02% 303

Other funds holding MET

Graypoint LLC's MET Position: Q2 2025 in Review

Graypoint LLC reduced its MetLife (MET) stake by 4.8% in Q2 2025, selling an estimated $34.3K and leaving 8,761 shares worth $705K. The position accounts for 0.04% of the portfolio, ranked #265.

Graypoint LLC first reported a position in MET in Q1 2022 and has held it in 10 quarters since. The position peaked at $739K in Q1 2025. 1,410 funds tracked by Wall St. Rank hold MET as of Q2 2025.

  • Graypoint LLC held 8,761 shares of MetLife worth $705K as of Q2 2025.
  • Graypoint LLC sold 445 MetLife shares in Q2 2025, an estimated $34.3K.
  • MetLife made up 0.04% of Graypoint LLC's portfolio in Q2 2025, its #265 holding.
  • Graypoint LLC first reported a position in MetLife in Q1 2022 and has held it in 10 quarters since.
  • Graypoint LLC's MetLife position peaked at $739K in Q1 2025.
  • 1,410 funds tracked by Wall St. Rank held MetLife as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.